What is Silence Therapeutics Plc American Depository Share's Enterprise Value?

Silence Therapeutics Plc American Depository Share's Enterprise Value is $1.8B, based on as-reported figures from SEC (XBRL) filings.

Silence Therapeutics Plc American Depository Share (SLN) Financial Statements

Silence Therapeutics Plc American Depository Share

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00WVTHQK3

XNAS · usd

13.41▼ 0.28 (-2.04%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close13.69

Day's Range13.40 – 14.47

52-Week Range4.17 – 17.58

Volume1.3M

Avg Volume1.5M

Share Statistics

Shares Outstanding

Employees88

ExchangeXNAS

Listed2020-09-08

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Silence Therapeutics Plc American Depository Share (SLN)

What is Silence Therapeutics Plc American Depository Share's Market Cap?: Silence Therapeutics Plc American Depository Share's Market Cap is $1.9B, based on as-reported figures from SEC (XBRL) filings.
What is Silence Therapeutics Plc American Depository Share's Enterprise Value?: Silence Therapeutics Plc American Depository Share's Enterprise Value is $1.8B, based on as-reported figures from SEC (XBRL) filings.
What is Silence Therapeutics Plc American Depository Share's Price / Sales?: Silence Therapeutics Plc American Depository Share's Price / Sales is 3090.9×, based on as-reported figures from SEC (XBRL) filings.
What is Silence Therapeutics Plc American Depository Share's EV / Revenue?: Silence Therapeutics Plc American Depository Share's EV / Revenue is 2973.8×, based on as-reported figures from SEC (XBRL) filings.
What is Silence Therapeutics Plc American Depository Share's EV / EBITDA?: Silence Therapeutics Plc American Depository Share's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Silence Therapeutics Plc American Depository Share's Revenue (TTM)?: Silence Therapeutics Plc American Depository Share's Revenue (TTM) is $615.0K, based on as-reported figures from SEC (XBRL) filings.
What is Silence Therapeutics Plc American Depository Share's Net Income (TTM)?: Silence Therapeutics Plc American Depository Share's Net Income (TTM) is -$60.0M, based on as-reported figures from SEC (XBRL) filings.
What is Silence Therapeutics Plc American Depository Share's EBITDA?: Silence Therapeutics Plc American Depository Share's EBITDA is -$68.0M, based on as-reported figures from SEC (XBRL) filings.
What is Silence Therapeutics Plc American Depository Share's Diluted EPS (TTM)?: Silence Therapeutics Plc American Depository Share's Diluted EPS (TTM) is -0.42, based on as-reported figures from SEC (XBRL) filings.
What is Silence Therapeutics Plc American Depository Share's EBITDA Margin?: Silence Therapeutics Plc American Depository Share's EBITDA Margin is -11057.6%, based on as-reported figures from SEC (XBRL) filings.